Bhavesh Ashar - Jan 6, 2022 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role: Chief Commercial Officer
Signature: /s/ Francis I. Perier, Jr. as Attorney-in Fact
Stock symbol: SWTX
Transactions as of: Jan 6, 2022
Transactions value $: $0
Form type: 4
Date filed: 1/10/2022, 03:23 PM
Next filing: Oct 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SWTX	Common Stock	Award		+13.1K	+104.5%		25.6K	Jan 6, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SWTX	Stock Option (Right to Buy)	Award	$0	+40.7K		$0.00	40.7K	Jan 6, 2022	Common Stock	40.7K	$59.46	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty three percent (33%) to vest on January 6, 2023, another thirty three percent (33%) to vest on January 6, 2024 and the remaining thirty four percent (34%) to vest on January 6, 2025, such that the restricted stock awards are fully vested on January 6, 2025.
F2	This option shall vest in 48 equal monthly installments subject to continued service to the company by the Reporting Person.